Boston Business Journal
Breaking News March 29, 2016

Feds charge Cambridge drug firm, former execs with misleading investors

Federal officials say executives at the firm committed fraud by failing to tell investors that the Food and Drug Administration explicitly recommended a second late-stage trial of its kidney cancer drug in 2012, a year before the drug was rejected.

Read the full story

If you are having trouble viewing this email, click here

Cancel Email Subscription

You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/

If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202

© 2016 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.